187 related articles for article (PubMed ID: 31115016)
1. Prognostic and predictive factors in testicular cancer.
Facchini G; Rossetti S; Berretta M; Cavaliere C; D'Aniello C; Iovane G; Mollo G; Capasso M; Della Pepa C; Pesce L; Facchini S; Imbimbo C; Pisconti S
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3885-3891. PubMed ID: 31115016
[TBL] [Abstract][Full Text] [Related]
2. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
3. Testicular germ-cell cancer.
Horwich A; Shipley J; Huddart R
Lancet; 2006 Mar; 367(9512):754-65. PubMed ID: 16517276
[TBL] [Abstract][Full Text] [Related]
4. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
5. Metachronous bilateral testicular germ cell tumors: report of two cases.
James FV; Kumar A; Jayaprakash PG; Mathews A
J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
[TBL] [Abstract][Full Text] [Related]
6. Testicular germ cell tumours in dogs are predominantly of spermatocytic seminoma type and are frequently associated with somatic cell tumours.
Bush JM; Gardiner DW; Palmer JS; Rajpert-De Meyts E; Veeramachaneni DN
Int J Androl; 2011 Aug; 34(4 Pt 2):e288-95; discussion e295. PubMed ID: 21615421
[TBL] [Abstract][Full Text] [Related]
7. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
9. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
10. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
11. [Testis germ cell tumours: which chemotherapy, for which patients?].
Fléchon A; Droz JP
Ann Urol (Paris); 2007 Apr; 41(2):56-67. PubMed ID: 17486913
[TBL] [Abstract][Full Text] [Related]
12. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
13. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
14. Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
Spinos T; Zografos E; Koutsoukos K; Zagouri F; Kosmas C; Driva TS; Goutas D; Gakiopoulou C; Agrogiannis G; Theochari E; Tzavara C; Lazaris AC
Int Urol Nephrol; 2024 Jun; 56(6):1887-1898. PubMed ID: 38285100
[TBL] [Abstract][Full Text] [Related]
15. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in the incidence of testicular germ cell tumors in the United States.
Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
[TBL] [Abstract][Full Text] [Related]
17. Treatment of early stage testicular seminoma.
Classen J; Souchon R; Hehr T; Bamberg M
J Cancer Res Clin Oncol; 2001 Aug; 127(8):475-81. PubMed ID: 11501746
[TBL] [Abstract][Full Text] [Related]
18. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
[TBL] [Abstract][Full Text] [Related]
19. GPR30 is overexpressed in post-puberal testicular germ cell tumors.
Franco R; Boscia F; Gigantino V; Marra L; Esposito F; Ferrara D; Pariante P; Botti G; Caraglia M; Minucci S; Chieffi P
Cancer Biol Ther; 2011 Mar; 11(6):609-13. PubMed ID: 21278491
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression.
Saeednejad Zanjani L; Razmi M; Fattahi F; Kalantari E; Abolhasani M; Saki S; Madjd Z; Mohsenzadegan M
J Cancer Res Clin Oncol; 2022 Mar; 148(3):609-631. PubMed ID: 34837545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
